Patterns of Use of Human Papillomavirus and Other Adolescent Vaccines in the United States

被引:31
|
作者
Vielot, Nadja A. [1 ]
Butler, Anne M. [2 ,3 ]
Brookhart, M. Alan [4 ]
Becker-Dreps, Sylvia [1 ]
Smith, Jennifer S. [4 ,5 ]
机构
[1] Univ North Carolina Chapel Hill, Sch Med, Dept Family Med, Chapel Hill, NC USA
[2] Washington Univ, Sch Med, Div Infect Dis, Dept Med, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA
[4] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, McGavran Greenberg Hall,CB 7435, Chapel Hill, NC 27599 USA
[5] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
Adolescents; Vaccination; Human papillomavirus; Coadministration; Health care providers; Tetanus-diphtheria-acellular pertussis vaccine; Meningococcal conjugate vaccine; AREA VACCINATION COVERAGE; AGED; 13-17; YEARS; ADVISORY-COMMITTEE; HPV VACCINATION; RECOMMENDATIONS; HEALTH; IMMUNOGENICITY; PREVENTION; DIPHTHERIA; PERTUSSIS;
D O I
10.1016/j.jadohealth.2017.05.016
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Purpose: The purpose of the study was to describe the patterns of use of universally recommended adolescent vaccines in the United States. Methods: We identified 11-year-olds using the MarketScan insurance claims database (2009e 2014). Human papillomavirus (HPV), tetanus-diphtheria-acellular pertussis (Tdap), and meningococcal (MenACWY) vaccination claims were identified using diagnosis and procedure codes. Generalized linear models estimated vaccination incidence rates and correlates of adolescent vaccination and timely vaccination. Results: Among 1,691,223 adolescents, receipt of Tdap (52.1%) and MenACWY (45.8%) vaccinations exceeded receipt of HPV vaccination (18.4%). While both sexes had similar Tdap and MenACWY vaccination proportions, girls received HPV vaccination more frequently than boys (21.9% vs. 15.1%). Adolescents received HPV vaccination later (mean age: 11.8 years) than Tdap or MenACWY vaccination (mean age: 11.2 years for both). Half of vaccinated adolescents received Tdap and MenACWY vaccination only; however, coadministration with HPV vaccine increased with birth cohort. Western adolescents had the highest incidence rates of HPV vaccination, and Southern adolescents had the lowest. Rural adolescents were less likely than urban adolescents to receive each vaccination except in the Northeast, where they were more likely to receive HPV vaccination (incidence rate ratio: 1.09, 95% confidence interval: 1.2005-1.13). Timely HPV vaccination was associated with female sex, urbanicity, Western residence, and later birth cohort. Conclusions: HPV vaccination occurred later than Tdap or MenACWY vaccination and was less frequent in boys and rural adolescents. Girls, Western and urban residents, and younger birth cohorts were more likely to receive timely HPV vaccination. Vaccine coadministration increased over time and may encourage timely and complete vaccination coverage. (C) 2017 Society for Adolescent Health and Medicine. All rights reserved.
引用
收藏
页码:281 / 287
页数:7
相关论文
共 50 条
  • [1] Patterns of Human Papillomavirus and Other Adolescent Vaccine Use in the United States
    Butler, Anne M.
    Vielot, Nadja A.
    Brookhart, M. Alan
    Becker-Dreps, Sylvia I.
    Smith, Jennifer S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 243 - 243
  • [2] Summer Peaks in Uptake of Human Papillomavirus and Other Adolescent Vaccines in the United States
    Moss, Jennifer L.
    Reiter, Paul L.
    Rimer, Barbara K.
    Ribisl, Kurt M.
    Brewer, Noel T.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (02) : 274 - 281
  • [3] Age-appropriate use of human papillomavirus vaccines in the United States
    Kinney, W.
    Fetterman, B.
    Akhtar, I.
    Husain, M.
    Gold, M. A.
    Guido, R.
    Castle, P. E.
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S34 - S35
  • [4] The impact of provider recommendation on human papillomavirus vaccine and other adolescent vaccines
    Caldwell, Alexandria C.
    Madden, Christi A.
    Thompson, David M.
    Garbe, M. Connor
    Roberts, James R.
    Jacobson, Robert M.
    Darden, Paul M.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (04) : 1059 - 1067
  • [5] Trends in Adolescent Human Papillomavirus Vaccination and Parental Hesitancy in the United States
    White, Jodie L.
    Grabowski, M. Kate
    Rositch, Anne F.
    Gravitt, Patti E.
    Quinn, Thomas C.
    Tobian, Aaron A. R.
    Patel, Eshan U.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (05): : 615 - 626
  • [6] FACTORS INFLUENCING ADOLESCENT HUMAN PAPILLOMAVIRUS VACCINATION UPTAKE IN THE UNITED STATES
    Sriram, S.
    Ranganathan, R.
    [J]. VALUE IN HEALTH, 2019, 22 : S190 - S190
  • [7] Role and uptake of human papillomavirus vaccine in adolescent health in the United States
    Sudenga, Staci L.
    Royse, Kathryn E.
    Shrestha, Sadeep
    [J]. ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2011, 2 : 63 - 74
  • [8] Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States
    Islam, Jessica Y.
    Gruber, Joann F.
    Kepka, Deanna
    Kunwar, Manju
    Smith, Sara B.
    Rothholz, Mitchel C.
    Brewer, Noel T.
    Smith, Jennifer S.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (7-8) : 1839 - 1850
  • [9] Japanese physicians' attitudes and intentions regarding human papillomavirus vaccine compared with other adolescent vaccines
    Katsuta, Tomohiro
    Moser, Charlotte A.
    Offit, Paul A.
    Feemster, Kristen A.
    [J]. PAPILLOMAVIRUS RESEARCH, 2019, 7 : 193 - 200
  • [10] Use of meningococcal vaccines in the United States
    Bilukha, Oleg
    Messonnier, Nancy
    Fischer, Marc
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (05) : 371 - 376